Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

220.75
+9.644.56%
Pre-market: 221.000.2500+0.11%06:40 EDT
Volume:1.23M
Turnover:273.29M
Market Cap:11.56B
PE:-58.58
High:229.62
Open:212.71
Low:212.44
Close:211.12
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:2.63
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:138.81
PE(LYR):-59.95

Loading ...

Definium's LSD-based depression pill delivers strong late-stage results, shares surge

Reuters
·
Jun 22

Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month

GlobeNewswire
·
Jun 18

Axsome Therapeutics price target raised to $300 from $275 at TD Cowen

TIPRANKS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 17

Axsome presents new Phase 3 ENCORE trial data for AXS-12 in narcolepsy with cataplexy at SLEEP 2026

Reuters
·
Jun 15

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

GlobeNewswire
·
Jun 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Axsome adopts executive severance, change-in-control plan effective June 5, 2026

Reuters
·
Jun 10

Axsome Therapeutics shareholders elect Saad, Mahony as Class II directors

Reuters
·
Jun 10

Axsome Therapeutics CEO Herriot Tabuteau disposes of USD 11.97 million in common shares

Reuters
·
Jun 10

Axsome CFO Nick Pizzie sells 33,000 shares for $7.92 million

Reuters
·
Jun 10

What Axsome Therapeutics (AXSM)'s SUNOSI Patent Settlements and Migraine Updates Mean For Shareholders

Simply Wall St.
·
Jun 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 04

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

GlobeNewswire
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

Axsome Therapeutics Reaches Settlement Over Sunosi Patent Dispute; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 03

BUZZ-Axsome Therapeutics rises after co resolves patent litigation for sleep disorder drug

Reuters
·
Jun 03